Skip to main content
. 2020 Oct 1;13(6):80. doi: 10.3892/mco.2020.2150

Table II.

Reasons for discontinuation of intensity-modulated radiation therapy/TMZ and 6 cycles of adjuvant TMZ.

Complication Number affected (%)
Disease progression 29 (20.6)
Bone marrow toxicity 20 (14.2)
Dysphagia 1 (0.7)
Cerebral hemorrhage 1 (0.7)
Cardiac arrest (unrelated) 1 (0.7)
Heart failure (unrelated) 1 (0.7)
Total 53 (37.6)

TMZ, temozolomide.